Get hands-on Botox® training in sunny Scottsdale, Arizona! The next Aesthetic Medicine Symposium runs September 5-8.

wegovy medication shortage

What Providers Need to Know: June 2025 GLP-1 Trends & Updates

May 2025 brought conclusive evidence that tirzepatide (Zepbound) produces substantially greater weight loss than semaglutide (Wegovy), with SURMOUNT-5 trial participants losing approximately 20% body weight on tirzepatide versus 14% on semaglutide. Beyond superior weight loss efficacy, GLP-1 medications demonstrated expanded therapeutic benefits for liver disease, cardiovascular health, sleep apnea, and even reduced alcohol consumption, transforming how providers should conceptualize these therapies from ‘weight loss drugs’ to comprehensive metabolic and organ-protective agents.

Read More »
Physician burnout

Funding Cuts, Burnout & Uncertainty? Build a More Secure Income with Aesthetic Medicine​

With funding cuts, shrinking reimbursements, and rising burnout rates, many physicians are looking for a more stable, flexible income stream. Aesthetic medicine offers a cash-based, high-profit alternative without the stress of insurance billing or long hospital shifts. In just a few days of training, providers can start offering in-demand, non-invasive treatments and take back control of their lives.

Read More »